CN101878198A - 苯基吡咯烷化合物 - Google Patents

苯基吡咯烷化合物 Download PDF

Info

Publication number
CN101878198A
CN101878198A CN2008801131031A CN200880113103A CN101878198A CN 101878198 A CN101878198 A CN 101878198A CN 2008801131031 A CN2008801131031 A CN 2008801131031A CN 200880113103 A CN200880113103 A CN 200880113103A CN 101878198 A CN101878198 A CN 101878198A
Authority
CN
China
Prior art keywords
pyrrolidin
methoxy
phenyl
disease
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2008801131031A
Other languages
English (en)
Chinese (zh)
Inventor
J·法拉构
A·帕洛莫
A·古格莱塔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferrer Internacional SA
Original Assignee
Ferrer Internacional SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Internacional SA filed Critical Ferrer Internacional SA
Publication of CN101878198A publication Critical patent/CN101878198A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN2008801131031A 2007-10-25 2008-10-23 苯基吡咯烷化合物 Pending CN101878198A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ESP200702800 2007-10-25
ES200702800A ES2331276B1 (es) 2007-10-25 2007-10-25 Compuestos de fenilpirrolidina.
PCT/EP2008/064390 WO2009053441A1 (en) 2007-10-25 2008-10-23 Phenylpyrrolidine compounds

Publications (1)

Publication Number Publication Date
CN101878198A true CN101878198A (zh) 2010-11-03

Family

ID=40291255

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008801131031A Pending CN101878198A (zh) 2007-10-25 2008-10-23 苯基吡咯烷化合物

Country Status (21)

Country Link
US (1) US20120184594A1 (cg-RX-API-DMAC7.html)
EP (1) EP2203422B1 (cg-RX-API-DMAC7.html)
JP (1) JP2011500764A (cg-RX-API-DMAC7.html)
KR (1) KR20100072287A (cg-RX-API-DMAC7.html)
CN (1) CN101878198A (cg-RX-API-DMAC7.html)
AR (1) AR069002A1 (cg-RX-API-DMAC7.html)
AT (1) ATE513809T1 (cg-RX-API-DMAC7.html)
AU (1) AU2008316473A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0817660A2 (cg-RX-API-DMAC7.html)
CA (1) CA2703458A1 (cg-RX-API-DMAC7.html)
CL (1) CL2008003141A1 (cg-RX-API-DMAC7.html)
DK (1) DK2203422T3 (cg-RX-API-DMAC7.html)
ES (2) ES2331276B1 (cg-RX-API-DMAC7.html)
MX (1) MX2010004469A (cg-RX-API-DMAC7.html)
PL (1) PL2203422T3 (cg-RX-API-DMAC7.html)
PT (1) PT2203422E (cg-RX-API-DMAC7.html)
RU (1) RU2010120845A (cg-RX-API-DMAC7.html)
SI (1) SI2203422T1 (cg-RX-API-DMAC7.html)
TW (1) TW200920353A (cg-RX-API-DMAC7.html)
UY (1) UY31425A1 (cg-RX-API-DMAC7.html)
WO (1) WO2009053441A1 (cg-RX-API-DMAC7.html)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753709A (en) * 1995-06-07 1998-05-19 Bristol-Myers Squibb Company N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
PT1189900E (pt) * 1999-06-30 2004-05-31 Bristol Myers Squibb Co Derivados de aminopirrolidina heterociclicos utilizados como agentes melatonergicos

Also Published As

Publication number Publication date
BRPI0817660A2 (pt) 2015-09-29
PT2203422E (pt) 2011-09-26
AR069002A1 (es) 2009-12-23
TW200920353A (en) 2009-05-16
JP2011500764A (ja) 2011-01-06
UY31425A1 (es) 2009-04-30
CA2703458A1 (en) 2009-04-30
SI2203422T1 (sl) 2011-10-28
EP2203422B1 (en) 2011-06-22
PL2203422T3 (pl) 2011-11-30
AU2008316473A1 (en) 2009-04-30
DK2203422T3 (da) 2011-10-10
MX2010004469A (es) 2010-07-06
ES2331276A1 (es) 2009-12-28
RU2010120845A (ru) 2011-11-27
ES2368697T3 (es) 2011-11-21
WO2009053441A1 (en) 2009-04-30
CL2008003141A1 (es) 2009-03-06
KR20100072287A (ko) 2010-06-30
US20120184594A1 (en) 2012-07-19
ATE513809T1 (de) 2011-07-15
ES2331276B1 (es) 2010-10-21
EP2203422A1 (en) 2010-07-07

Similar Documents

Publication Publication Date Title
EP3854782A1 (en) Substituted benzamides and methods of use thereof
US20160297754A1 (en) N-substituted benzamides and methods of use thereof
CN105130957A (zh) 作为钙或钠通道阻滞剂的芳基取代羧酰胺衍生物
JP2020530848A (ja) 3,4−二置換3−シクロブテン−1,2−ジオンおよびその使用
WO2009136625A1 (ja) 環状アミン-1-カルボン酸エステル誘導体およびそれを含有する医薬組成物
CZ20032145A3 (cs) 4-Aminobenzopyranové deriváty
CA2731405A1 (en) 1,6-dihydro-2h-3-oxa-6-aza-as-indacene compounds
JP2011500763A (ja) インドリン化合物
CN101868450A (zh) 2,3-二氢-苯并呋喃化合物
EP2266975A1 (en) 1-(2-alkyl-2,3-dihydro-benzofuran-4-yl)-pyrrolidin-3-ylamine acyl compounds
EP2203422B1 (en) Phenylpyrrolidine compounds
HK1145680A (en) Phenylpyrrolidine compounds
HK1145327A (en) Compounds of 2,3-dihydro-benzofuran
JP2026513014A (ja) ベンゾジアゼピン系化合物及びそのRhoキナーゼ阻害剤としての応用
HK1145679A (en) Indoline compounds
HK1260284B (en) Substituted piperidine compound and use thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1145680

Country of ref document: HK

AD01 Patent right deemed abandoned

Effective date of abandoning: 20101103

C20 Patent right or utility model deemed to be abandoned or is abandoned
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1145680

Country of ref document: HK